Cargando…

Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study

OBJECTIVE: To study data about SARS-CoV-2 virus shedding and clarify the risk factors for prolonged virus shedding. METHODS: Data were retrospectively collected from adults hospitalized with laboratory-confirmed coronavirus disease-19 (COVID-19) in Wuhan Union Hospital. We compared clinical features...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xin-liang, Zhou, Ya-ya, Fu, Wei, Xue, Yu-e, Liang, Meng-yuan, Yang, Bo-han, Ma, Wan-li, Zhou, Qiong, Chen, Long, Zhang, Jian-chu, Wang, Xiao-rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Huazhong University of Science and Technology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436017/
https://www.ncbi.nlm.nih.gov/pubmed/34515914
http://dx.doi.org/10.1007/s11596-021-2434-y
_version_ 1783751917996867584
author He, Xin-liang
Zhou, Ya-ya
Fu, Wei
Xue, Yu-e
Liang, Meng-yuan
Yang, Bo-han
Ma, Wan-li
Zhou, Qiong
Chen, Long
Zhang, Jian-chu
Wang, Xiao-rong
author_facet He, Xin-liang
Zhou, Ya-ya
Fu, Wei
Xue, Yu-e
Liang, Meng-yuan
Yang, Bo-han
Ma, Wan-li
Zhou, Qiong
Chen, Long
Zhang, Jian-chu
Wang, Xiao-rong
author_sort He, Xin-liang
collection PubMed
description OBJECTIVE: To study data about SARS-CoV-2 virus shedding and clarify the risk factors for prolonged virus shedding. METHODS: Data were retrospectively collected from adults hospitalized with laboratory-confirmed coronavirus disease-19 (COVID-19) in Wuhan Union Hospital. We compared clinical features among patients with prolonged (a positive SARS-CoV-2 RNA on day 23 after illness onset) and short virus shedding and evaluated risk factors associated with prolonged virus shedding by multivariate regression analysis. RESULTS: Among 238 patients, the median age was 55.5 years, 57.1% were female, 92.9% (221/238) were administered with arbidol, 58.4% (139/238) were given arbidol in combination with interferon. The median duration of SARS-CoV-2 virus shedding was 23 days (IQR, 17.8–30 days) with a longest one of 51 days. The patients with prolonged virus shedding had higher value of D-dimer (P=0.002), IL-6 (P<0.001), CRP (P=0.005) and more lobes lung lesion (P=0.014) on admission, as well as older age (P=0.017) and more patients with hypertension (P=0.044) than in those the virus shedding less than 23 days. Multivariate regression analysis revealed that prolonged viral shedding was significantly associated with initiation arbidol >8 days after symptom onset [OR: 2.447, 95% CI (1.351–4.431)], ≥3 days from onset of symptoms to first medical visitation [OR: 1.880, 95% CI (1.035–3.416)], illness onset before Jan. 31, 2020 [OR: 3.289, 95% CI (1.474–7.337)]. Arbidol in combination with interferon was also significantly associated with shorter virus shedding [OR: 0.363, 95% CI (0.191–0.690)]. CONCLUSION: Duration of SARS-CoV-2 virus shedding was long. Early initiation of arbidol and arbidol in combination with interferon as well as consulting doctor timely after illness onset were helpful for SARS-CoV-2 clearance. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.1007/s11596-021-2434-y and is accessible for authorized users.
format Online
Article
Text
id pubmed-8436017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Huazhong University of Science and Technology
record_format MEDLINE/PubMed
spelling pubmed-84360172021-09-13 Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study He, Xin-liang Zhou, Ya-ya Fu, Wei Xue, Yu-e Liang, Meng-yuan Yang, Bo-han Ma, Wan-li Zhou, Qiong Chen, Long Zhang, Jian-chu Wang, Xiao-rong Curr Med Sci Article OBJECTIVE: To study data about SARS-CoV-2 virus shedding and clarify the risk factors for prolonged virus shedding. METHODS: Data were retrospectively collected from adults hospitalized with laboratory-confirmed coronavirus disease-19 (COVID-19) in Wuhan Union Hospital. We compared clinical features among patients with prolonged (a positive SARS-CoV-2 RNA on day 23 after illness onset) and short virus shedding and evaluated risk factors associated with prolonged virus shedding by multivariate regression analysis. RESULTS: Among 238 patients, the median age was 55.5 years, 57.1% were female, 92.9% (221/238) were administered with arbidol, 58.4% (139/238) were given arbidol in combination with interferon. The median duration of SARS-CoV-2 virus shedding was 23 days (IQR, 17.8–30 days) with a longest one of 51 days. The patients with prolonged virus shedding had higher value of D-dimer (P=0.002), IL-6 (P<0.001), CRP (P=0.005) and more lobes lung lesion (P=0.014) on admission, as well as older age (P=0.017) and more patients with hypertension (P=0.044) than in those the virus shedding less than 23 days. Multivariate regression analysis revealed that prolonged viral shedding was significantly associated with initiation arbidol >8 days after symptom onset [OR: 2.447, 95% CI (1.351–4.431)], ≥3 days from onset of symptoms to first medical visitation [OR: 1.880, 95% CI (1.035–3.416)], illness onset before Jan. 31, 2020 [OR: 3.289, 95% CI (1.474–7.337)]. Arbidol in combination with interferon was also significantly associated with shorter virus shedding [OR: 0.363, 95% CI (0.191–0.690)]. CONCLUSION: Duration of SARS-CoV-2 virus shedding was long. Early initiation of arbidol and arbidol in combination with interferon as well as consulting doctor timely after illness onset were helpful for SARS-CoV-2 clearance. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.1007/s11596-021-2434-y and is accessible for authorized users. Huazhong University of Science and Technology 2021-09-13 2021 /pmc/articles/PMC8436017/ /pubmed/34515914 http://dx.doi.org/10.1007/s11596-021-2434-y Text en © Huazhong University of Science and Technology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
He, Xin-liang
Zhou, Ya-ya
Fu, Wei
Xue, Yu-e
Liang, Meng-yuan
Yang, Bo-han
Ma, Wan-li
Zhou, Qiong
Chen, Long
Zhang, Jian-chu
Wang, Xiao-rong
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study
title Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study
title_full Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study
title_fullStr Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study
title_full_unstemmed Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study
title_short Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study
title_sort prolonged sars-cov-2 viral shedding in patients with covid-19 was associated with delayed initiation of arbidol treatment and consulting doctor later: a retrospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436017/
https://www.ncbi.nlm.nih.gov/pubmed/34515914
http://dx.doi.org/10.1007/s11596-021-2434-y
work_keys_str_mv AT hexinliang prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT zhouyaya prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT fuwei prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT xueyue prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT liangmengyuan prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT yangbohan prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT mawanli prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT zhouqiong prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT chenlong prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT zhangjianchu prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy
AT wangxiaorong prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy